x

Zoek een klinische studie of trial

* (*) verplicht veld

10 Resultaat/Resultaten

Aanwerving proef = Aanwerving proef
; Lopend onderzoek = Lopend onderzoek
; Gefinancierd door een IRDiRC-lid = ; Member of a ERN =

Nationale klinische studie(s)

VERENIGD KONINKRIJK

Greater London
LONDON

CMT-TRAUK: Randomised double blind placebo controlled trial of long term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (Phase III) (Completed)
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

VERENIGD KONINKRIJK

Greater London
LONDON

PADIMAC: Phase II study of Bortezomib, Adriamycin and Dexamethasone (PAD) therapy for previously untreated patients with multiple myeloma: Impact of minimal residual disease (MRD) in patients with deferred ASCT - UK
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

VERENIGD KONINKRIJK

Greater London
LONDON

Bortezomib Consolidation Trial: A Phase II study of bortezomib consolidation after high dose therapy and autologous stem cell transplantation for multiple myeloma - UK
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

VERENIGD KONINKRIJK

Greater London
LONDON

Lopend onderzoek
An Open-Label, Multicenter, Extension Study of AG-348 in Adult Subjects With Pyruvate Kinase Deficiency Previously Enrolled in AG-348 Studies-GB
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

VERENIGD KONINKRIJK

Greater London
LONDON

Lopend onderzoek
Gefinancierd door een IRDiRC-lidPhase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM) - GB
UCL Institute of Neurology, University College London,
Clinical Neurosciences

VERENIGD KONINKRIJK

Greater London
LONDON

VERENIGD KONINKRIJK

Greater London
LONDON

Aanwerving proef
Lopend onderzoek
COBALT: Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation
University College London Hospitals NHS Foundation Trust
Cancer Division